Not affected by “smoke” The accuracy of the new generation of cancer screening tool DR-70 is better than that of traditional CEA, which has been approved by the European Union, the US FDA and the Ministry of Health and Welfare of Taiwan, and is used to detect fibrin degraders (FDP) in the blood for postoperative screening of colorectal cancer. Dr. Wei explained that since malignant tumors produce fibrin when they grow, and then secrete catalysts to promote fibrin lysis and produce fibrin degradants (FDP), DR-70 is to detect the concentration of FDP in the serum to determine whether there are signs of cancer recurrence, providing valuable disease detection information for the medical team.
Link: Business Times http://ctee.com.tw/News/View.aspx?newsid=26859&cat=2
